1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL CONTRAST AGENT MARKET BY TYPE
5.1. Introduction
5.2. Iodinated
5.3. Barium-based
5.4. Microbubble
5.5. Gadolinium-based
6. GLOBAL CONTRAST AGENT MARKET BY MODALITY
6.1. Introduction
6.2. X-ray/CT
6.3. MRI
6.4. Ultrasound
7. GLOBAL CONTRAST AGENT MARKET BY ROUTE OF ADMINISTRATION
7.1. Introduction
7.2. Intravascular
7.3. Oral
7.4. Rectal
7.5. Others
8. GLOBAL CONTRAST AGENT MARKET BY INDICATION
8.1. Introduction
8.2. Oncology
8.3. Cardiovascular Disease
8.4. Neurological Disorders
8.5. Gastrointestinal Disorders
8.6. Nephrological Disorders
8.7. Musculoskeletal Disorders
8.8. Others
9. GLOBAL CONTRAST AGENT MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. United Kingdom
9.4.2. Germany
9.4.3. France
9.4.4. Spain
9.4.5. Others
9.5. Middle East & Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. Japan
9.6.2. China
9.6.3. India
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Guerbet Group
11.2. Bayer AG
11.3. Lantheus Medical Imaging, Inc.
11.4. Bracco Diagnostic, Inc.
11.5. GE
11.6. Curadel, LLC
11.7. Daiichi Sankyo Company, Limited
11.8. Magnus Health
11.9. Spago Nanomedical AB
11.10. J.B. Chemicals & Pharmaceuticals Ltd
12. RESEARCH METHODOLOGY
LIST OF FIGURES
LIST OF TABLES